Common diagnostic problems in pediatric liver pathology

Clinics in Liver Disease

Volumn 6, Issue 2, 2002, Pages 421-454

  Finegold, Milton J ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIARY CIRRHOSIS; CHOLANGITIS; CHOLESTASIS; EXTRAHEPATIC BILE DUCT OBSTRUCTION; HEPATITIS; HISTOPATHOLOGY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER NECROSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; ADOLESCENT; AUTOIMMUNE HEPATITIS; BIOPSY; CHILD; HUMAN; INFANT; LIVER; LIVER FAILURE; LIVER TUMOR; NEWBORN; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; CHOLESTASIS; HEPATITIS, AUTOIMMUNE; HUMAN; INFANT; INFANT, NEWBORN; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FAILURE; LIVER NEOPLASMS; HUMANS;

EID: 0035986527     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(02)00014-4     Document Type: Review

References (105)

1. Histopathologic approach to metabolic liver disease (in 2 parts)
2. Abnormal bile acid metabolism and neonatal hemochromatosis: A subset with poor prognosis
3. Rapid development of hepatocellular siderosis after liver transplantation for neonatal hemochromatosis
4. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: Clinical overlap with neonatal hemochromatosis
5. Severe perinatal liver disease and Down syndrome: All apparent relationship
6. Hepatic failure
7. Liver failure in children with hepatitis A
8. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features
9. Neonatal syncytial giant cell hepatitis with paramyxoviral-like inclusions
10. Adult syncytial giant cell hepatitis due to herbal remedy
11. Peliosis hepatis with initial presentation as acute hepatic failure and intraperitoneal hemorrhage in children
12. Medical complications in long-term survivors of myotubular myopathy
13. The lidocaine (MEGX) test as an index of hepatic function: Its clinical usefulness in liver surgery
14. Evaluation of hepatic function in liver cirrhosis: Clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol and laboratory investigations
15. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: Comparison between hepatocyte volume and liver volume by computed tomography
16. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass
17. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes
18. Hepatocellular transplantation (HCT) in children with fulminant liver failure (FLF)
19. Hepatocyte transplantation
20. Hepatocyte transplantation for the treatment of human disease
21. A case of syncytial giant cell hepatitis treated with an extra corporeal liver assist device
22. Childhood liver disease and metabolic disorders
23. Pediatric hepatology. A half-century of progress
24. Liver biopsy interpretation
25. MR cholangiography in the evaluation of neonatal cholestasis
26. The mannose-binding lectin gene influences the severity of chronic liver disease in cystic fibrosis
27. Paucity of interlobular bile ducts
28. Neonatal cholestasis
29. Pathogenesis of ductal plate abnormalities
30. Biliary atresia: New concepts of management
31. Outcome of early hepatoportoenterostomy for biliary atresia
32. The Kasai portoenterostomy: When is it too late?
33. Ductal remnants in extrahepatic biliary atresia: A histopathologic study with clinical correlation
34. Does the morphology of the extrahepatic biliary remnants in bilibary atresia influence survival? A review of 205 cases
35. Infantile liver giant cells: Immunohistological study of their proliferative state and possible mechanisms of their formation
36. Cytomegalovirus and human herpes virus 6 but not human papillomavirus are present in neonatal giant cell hepatitis and extrahepatic biliary atresia
37. Liver disease caused by disorders of bile acid synthesis
38. Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis
39. Progressive familial cholestasis. Genetic basis and treatment
40. Progressive familial intrahepatic cholestasis, a personal perspective
41. Niemann-Pick like liver disease and reduced cholesterol esterification in fibroblasts of two male infants
42. Mutation analysis of Jagged 1 (JAG 1) in Alagille syndrome patients
43. Alagille syndrome: The widening spectrum of arteriohepatic dysplasia
44. Obliterative cholangitis due to cytomegalovirus: A possible precursor of paucity of intrahepatic bile ducts
45. Ischemic necrosis of bile ducts complicating Schonlein-Henoch purpura
46. The DSL domain in mutant JAG 1 ligand is essential for the severity of the liver defect in Alagille syndrome
47. Cholestatic jaundice and congenital hypopituitarism
48. Investigation and outcome of neonatal hepatitis in infants with hypopituitarism
49. Systemic disease and the liver
50. Cholestasis in premature infants: Is parenteral alimentation responsible?
51. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 Years' experience
52. Sclerosing cholangitis
53. Primary sclerosing cholangitis in children
54. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study
55. Protracted but not acute hepatitis A infection is strongly associated with HLA-DRB 1301, a marker for pediatric autoimmune hepatitis
56. Copper and iron storage disorders
57. Idiopathic copper toxicosis
58. Liver disease in Navajo neuropathy
59. Viral hepatitis. From prevention to antivirals
60. A prospective study on mother-to-infant transmission of hepatitis C virus
61. Liver tumors
62. Fatal veno-occlusive disease in a newborn infant
63. Hepatic veno-occlusive disease in ataxia-telangiectasia
64. Congenital hepatic fibrosis in three siblings with phosphomannose isomerase deficiency
65. Liver pathology in the carbohydrate deficient glycoprotein syndrome
66. North American Indian cirrhosis in children: A review of 30 cases
67. Measurement of serum hyaluronic acid in patients with chronic hepatitis: Its relationship to liver histology
68. Hepatic perfusion parameters in chronic liver disease: Dynamic CT measurements correlated with disease severity
69. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: A 10 year follow-up
70. Malignant hepatic tumors in children: Incidence, clinical features and aetiology
71. Liver tumors in neonates and very young infants: Diagnostic pitfalls and therapeutic problems
72. Association between hepatoblastoma and very low birth weight: A trend or a chance
73. Prematurity and hepatoblastoma: More than just an association?
74. Liver tumors
75. Infantile hemangio-endothelioma with highly elevated alphafetoprotein level
76. Tumors of the liver
77. Fine needle aspiration cytology of pediatric patients with primary hepatic tumors
78. Neoplasms and nodules in children
79. Hepatic tumors in children
80. Treatment of pulmonary metastases of initial stage I hepatobastoma in childhood
81. Small cell undifferentiated histology in hepatoblastoma may be unfavorable histology
82. Malignant potential of mesenchymal hamartoma: An unrecognized risk
83. Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma
84. Comparative genomic hybridization detects multiple chromosomal amplifications and deletions in undifferentiated embryonal sarcoma of the liver
85. Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: Report of a case and review of literature
86. Mesenchymal hamartoma of the liver in Beckwith-Wiedemann syndrome. The first reported case
87. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann syndrome registry
88. Liver transplantation: The pediatric challenge
89. Identifying the patient at risk for post transplant lymphoproliferative disorder
90. Post transplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation
91. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related post-transplant lymphoproliferative disease in pediatric liver transplant recipients treated with tacrolimus
92. Epstein-Barr virus serology and Epstein-Barr virus associated lymphoproliferative disorders in pediatric liver transplant recipients
93. Liver transplant pathology in pediatric metabolic disorders
94. Tyrosinemia
95. Microvesicular steatosis, hemosiderosis and rapid development of cirrhosis in a patient with Pearson's syndrome
96. Jeune syndrome and liver disease: Report of three cases treated with ursodeoxycholic acid
97. Recurrent post-infantile syncytial giant cell hepatitis after orthotopic liver transplantation
98. Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation
99. Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and auto-immune hepatitis
100. Intrahepatic cholestasis in neonatal lupus erythematosus
101. Sclerosing cholangitis and ulcerative colitis in a mother and her son
102. Demonstration of McCune-Albright mutations in the liver of children with high gamma GT progressive cholestasis
103. Liver transplantation for biliary atresia associated with malignant hepatic tumors
104. Infantile cholestatic jaundice associated with adult-onset type II citrullinemia
105. Echovirus hepatic failure in infancy: Report of four cases with speculation on the pathogenesis